F. Pagani et al., EFFECTS OF AMYLIN AND SALMON-CALCITONIN ON BETA-ENDORPHIN-INDUCED GROWTH-HORMONE AND PROLACTIN SECRETION IN THE RAT, Neuroendocrinology, 68(3), 1998, pp. 220-228
In this study we examined the possible interplay of amylin (AMY) and s
almon calcitonin (sCT) in the central control of growth hormone (GH) a
nd prolactin (PRL) secretion in male rats. For this purpose we first c
ompared effects of central intracerebroventricular (i.c.v.) administra
tion of various doses of AMY (2.5-2,500 ng/rat) and sCT (2.2-220 ng/ra
t) on beta-endorphin (beta-END, 0.5 mu g/rat)-induced GH and PRL secre
tion. AMY and sCT dose-dependently inhibited beta-END-induced GH secre
tion, whereas only sCT was able to inhibit beta-END-induced PRL secret
ion. To examine whether the GH inhibitory effect of AMY was due to the
possible cross-reactivity of AMY and sCT on the same receptors in the
CNS, we pretreated some rats with the AMY antagonist (AMY(8-37), 2.5
mu g/rat, i.c.v.). AMY(8-37) significantly enhanced the GH-stimulatory
action of beta-END. AMY(8-37), administered prior to AMY and sCT, sig
nificantly removed the inhibitory effect of both AMY and sCT on beta-E
ND-induced GH release, suggesting that both peptides mediate their res
ponse on GH through a common receptor. In vitro competition binding st
udies on rat hypothalamic membranes have shown that both AMY and sCT c
ompete with [I-125]rAMY binding with half inhibition (IC50) values of
3.6 x 10(-11) and 1.6 x 10(-10) M, respectively. Binding of [I-125]sCT
was inhibited by sCT with an IC50 of 1.09 x 10(-10) M and to a lesser
extent by AMY with an IC50 of 1.3 x 10(-6) M. Thus it is possible tha
t the two peptides recognize a common hypothalamic receptor but with d
ifferent affinities (sCT > AMY). Overall these data indicate that AMY
behaves as a mimic of sCT in the central control of GH secretion. The
failure of AMY, at variance with sCT, to modify the PRL- releasing act
ivity of beta-END indicates that different receptor subtypes for sCT a
re involved in the endocrine effects of sCT and only those mediating t
he modulatory action of GH respond to AMY.